We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

162 hedge funds and large institutions have $1.23B invested in Aerie Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,450% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 4

300% more funds holding in top 10

Funds holding in top 10: 2 → 8 (+6)

151% more capital invested

Capital invested by funds: $489M → $1.23B (+$737M)

56% more funds holding

Funds holding: 104 → 162 (+58)

40% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 35

29% more call options, than puts

Call options by funds: $34.6M | Put options by funds: $26.8M

Holders
162
Holders Change
+58
Holders Change %
+55.77%
% of All Funds
4.32%
Holding in Top 10
8
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+300%
% of All Funds
0.21%
New
62
Increased
49
Reduced
35
Closed
4
Calls
$34.6M
Puts
$26.8M
Net Calls
+$7.76M
Net Calls Change
+$3.48M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$17.6M
2
FCMI
Foresite Capital Management II
California
+$15.4M
3
Citadel Advisors
Citadel Advisors
Florida
+$12.3M
4
ACA
Avoro Capital Advisors
New York
+$11M
5
Ameriprise
Ameriprise
Minnesota
+$9.67M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$26.1M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$9.91M
3
PHS
PFM Health Sciences
California
-$8.27M
4
NC
Northpointe Capital
Michigan
-$4.54M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$4.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Voloridge Investment Management
76
Voloridge Investment Management
Florida
$1.62M +$948K +43,007 New
PIM
77
Partner Investment Management
California
$1.6M -$42.1K -1,907 -4%
ECM
78
Endurant Capital Management
California
$1.59M +$190K +8,630 +26%
MCM
79
Moore Capital Management
New York
$1.51M +$882K +40,000 New
CCM
80
Convector Capital Management
New York
$1.45M -$370K -16,756 -30%
TA
81
Teachers Advisors
New York
$1.44M – – –
AA
82
ALPS Advisors
Colorado
$1.34M -$37.7K -1,710 -5%
CS
83
Candriam SCA
Luxembourg
$1.28M +$750K +34,000 New
SCM
84
Suffolk Capital Management
New York
$1.28M -$1.88M -85,100 -72%
New York State Common Retirement Fund
85
New York State Common Retirement Fund
New York
$1.27M +$22.3K +1,013 +3%
GC
86
Guggenheim Capital
Illinois
$1.24M +$722K +32,751 New
EGM
87
Engineers Gate Manager
New York
$1.11M +$647K +29,321 New
Group One Trading
88
Group One Trading
Illinois
$1.02M +$595K +26,971 New
T. Rowe Price Associates
89
T. Rowe Price Associates
Maryland
$1.01M +$588K +26,660 New
LCM
90
Leisure Capital Management
California
$969K -$3.31K -150 -0.6%
CS
91
Credit Suisse
Switzerland
$951K -$253K -11,495 -31%
DILH
92
Dai-ichi Life Holdings
Japan
$917K +$536K +24,286 New
LCM
93
Laurion Capital Management
New York
$917K +$536K +24,300 New
RhumbLine Advisers
94
RhumbLine Advisers
Massachusetts
$907K +$23.4K +1,062 +5%
CG
95
Cutler Group
California
$903K +$327K +14,840 +163%
State Board of Administration of Florida Retirement System
96
State Board of Administration of Florida Retirement System
Florida
$895K -$19.2K -870 -4%
SSA
97
Schonfeld Strategic Advisors
New York
$877K +$248K +11,241 +94%
TRSOTSOK
98
Teachers Retirement System of the State of Kentucky
Kentucky
$836K -$248K -11,261 -34%
HighTower Advisors
99
HighTower Advisors
Illinois
$794K +$466K +21,124 New
EMG
100
Ellington Management Group
Connecticut
$759K +$443K +20,100 New
2 3
4
5 6

AERI Hedge Fund Activity: Q3 2016 in Review

162 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2016, worth a combined $1.23B — up 151% from $489M a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new AERI positions and 4 closed out — a net gain of 58 holders — while 49 added to existing stakes and 35 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $17.6M. The largest seller was Deerfield Management, cutting an estimated $26.1M.

  • 162 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2016, up from 104 in Q2 2016.
  • Funds reported $1.23B of Aerie Pharmaceuticals stock for Q3 2016, up 151% quarter-over-quarter.
  • 62 funds opened new Aerie Pharmaceuticals positions in Q3 2016 and 4 closed out, a net change of +58 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2016 was OrbiMed, an estimated $17.6M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2016 was Deerfield Management, an estimated $26.1M sold.

Based on aggregated 13F filings for Q3 2016.